1. Home
  2. IRWD vs STHO Comparison

IRWD vs STHO Comparison

Compare IRWD & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • STHO
  • Stock Information
  • Founded
  • IRWD 1998
  • STHO N/A
  • Country
  • IRWD United States
  • STHO United States
  • Employees
  • IRWD N/A
  • STHO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • STHO Real Estate
  • Sector
  • IRWD Health Care
  • STHO Real Estate
  • Exchange
  • IRWD Nasdaq
  • STHO Nasdaq
  • Market Cap
  • IRWD 111.2M
  • STHO 89.7M
  • IPO Year
  • IRWD 2010
  • STHO N/A
  • Fundamental
  • Price
  • IRWD $0.82
  • STHO $7.75
  • Analyst Decision
  • IRWD Buy
  • STHO
  • Analyst Count
  • IRWD 5
  • STHO 0
  • Target Price
  • IRWD $4.94
  • STHO N/A
  • AVG Volume (30 Days)
  • IRWD 1.5M
  • STHO 150.9K
  • Earning Date
  • IRWD 08-07-2025
  • STHO 08-05-2025
  • Dividend Yield
  • IRWD N/A
  • STHO N/A
  • EPS Growth
  • IRWD N/A
  • STHO N/A
  • EPS
  • IRWD N/A
  • STHO N/A
  • Revenue
  • IRWD $317,676,000.00
  • STHO $113,297,000.00
  • Revenue This Year
  • IRWD N/A
  • STHO N/A
  • Revenue Next Year
  • IRWD N/A
  • STHO N/A
  • P/E Ratio
  • IRWD N/A
  • STHO N/A
  • Revenue Growth
  • IRWD N/A
  • STHO N/A
  • 52 Week Low
  • IRWD $0.53
  • STHO $6.06
  • 52 Week High
  • IRWD $7.11
  • STHO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 56.06
  • STHO 49.93
  • Support Level
  • IRWD $0.67
  • STHO $7.68
  • Resistance Level
  • IRWD $0.92
  • STHO $8.09
  • Average True Range (ATR)
  • IRWD 0.07
  • STHO 0.22
  • MACD
  • IRWD 0.01
  • STHO -0.05
  • Stochastic Oscillator
  • IRWD 58.52
  • STHO 30.43

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

Share on Social Networks: